Search results for Fidson

Fidson Champions Wellness at Chessmasters 2026

One of Nigeria’s Leading Pharmaceutical Companies Brings Wellness, Play, and Purpose to Africa’s Largest School Chess Tournament The post Fidson Champions Wellness at Chessmasters...

Fredun enters high-value hormone therapeutics segment with new speciality brand launch

The initiative marks Fredun’s push into high-value, innovation-driven pharmaceutical segments.

Fredun enters high-value hormone therapeutics segment with new speciality brand launch

The initiative marks Fredun’s push into high-value, innovation-driven pharmaceutical segments.

Pharma Stock in Focus After Receiving USFDA Approval for Benzonatate Capsules

Synopsis: The shares of this company rose 8.9 percent following a press release announcing USFDA approval for its Benzonatate Capsules, boosting investor confidence. The share of t...

Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy

Angelini Pharma’s acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst’s top product is Firdapse, the first FDA-...

<![CDATA[Pharmaceutical Executive Daily: Idvynso Receives FDA Approval]]>

Sam Pharmaceuticals opens Factory in Nigeria with FCMB, BoI Support

Sam Pharmaceutical Limited has opened a new manufacturing facility in southwestern Nigeria, expanding local drug production capacity as the country pushes to reduce reliance on imp...

FidBank UK broadens investment pathways for Nigerians into UK market

The event was attended by a select audience comprising captains of industry and corporate leaders The post FidBank UK broadens investment pathways for Nigerians into UK market appe...

AIICO, Ikeja Hotel, Fidson top stock picks this week

This is not a buy, sell or hold recommendation but a stock investment guide. You may need to involve your financial advisor before making investment decisions. The post AIICO, Ikej...

Protalix: Elfabrio Struggles Against Oral Competition

<![CDATA[Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Ar...

FidBank UK Expands Investment Opportunities for Nigerians with New UK Property Financing Solutions

FidBank UK has expanded investment opportunities for Nigerians with new UK Property Financing Solutions.   NewsOnline Nigeria reports that FidBank UK Limited, the international sub...

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

This product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Tessalon Capsules, 100 mg and 200 mg, of Pfizer Inc

FORTIVE

FORTIVE Anonymous (not verified) Tue, 04/28/2026 - 14:16 field_thread_url https://cafepharma.com/boards/threads/fortive.629727/ board na...

<![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>

FORTIVE

FORTIVE Anonymous (not verified) Mon, 04/27/2026 - 11:16 field_thread_url https://cafepharma.com/boards/threads/fortive.629727/ board na...

<![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>

<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>

<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>

Zydus and Lupin Join Alembic in 180-Day Sprint for $10.5 Billion Dapagliflozin Market

Synopsis: Zydus, Lupin, and Biocon join Alembic in a high-stakes US launch of generic Farxiga, sharing 180-day exclusivity for a blockbuster diabetes drug with $10.5 billion in ann...

<![CDATA[Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava]]>

Pfizer deals extend patent life for a top-selling rare disease drug

Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and have implications for others, including BridgeBio Pharma and Alnylam. 

AIICO, Fidelity, May & Baker top stock pick this week

This is not a buy, sell or hold recommendation but a stock investment guide. You may need to involve your financial advisor before taking investment decisions. The post AIICO, Fide...

₹94 Pharma-Chemical Stock: Global Ibuprofen Leader With New API Expansion Plans

Synopsis: This Pharma-Chemical stock is a global Ibuprofen leader with a large integrated manufacturing base, low debt and new API expansion plans. But the bigger question is wheth...